Hepatology

Copyright © 2013 American Association for the Study of Liver Diseases

Cover image for Vol. 55 Issue 6

June 2012

Volume 55, Issue 6

Pages 1647–2044

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. The gut-liver axis: A busy two-way street (pages 1647–1649)

      Wajahat Z. Mehal

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25704

    2. Living and dying well with end-stage liver disease: Time for palliative care? (pages 1650–1651)

      Kirsty Boyd, Barbara Kimbell, Scott Murray and John Iredale

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25621

  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 (pages 1652–1661)

      Maxine M. Denniston, R. Monina Klevens, Geraldine M. McQuillan and Ruth B. Jiles

      Article first published online: 10 APR 2012 | DOI: 10.1002/hep.25556

    2. A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A–mediated translation and virus production (pages 1662–1672)

      Ronik Khachatoorian, Vaithilingaraja Arumugaswami, Piotr Ruchala, Santanu Raychaudhuri, Eden M. Maloney, Edna Miao, Asim Dasgupta and Samuel W. French

      Article first published online: 30 JAN 2012 | DOI: 10.1002/hep.25533

    3. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo (pages 1673–1683)

      Qiuwei Pan, Petra E. de Ruiter, Herold J. Metselaar, Jaap Kwekkeboom, Jeroen de Jonge, Hugo W. Tilanus, Harry L.A. Janssen and Luc J.W. van der Laan

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25562

    4. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution (pages 1684–1691)

      Lin Liu, Brian E. Fisher, David L. Thomas, Andrea L. Cox and Stuart C. Ray

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25575

    5. Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052 (pages 1692–1699)

      Jin-Hua Sun, Donald R. O'Boyle II, Yan Zhang, Chunfu Wang, Peter Nower, Lourdes Valera, Susan Roberts, Richard E. Nettles, Robert A. Fridell and Min Gao

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25581

    6. Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection (pages 1700–1710)

      Janett Fischer, Stephan Böhm, Markus Scholz, Tobias Müller, Heiko Witt, Jacob George, Christoph Sarrazin, Simone Susser, Eckart Schott, Vijayaprakash Suppiah, David R. Booth, Graeme J. Stewart, Florian van Bömmel, Annika Brodzinski, Balazs Fülöp, Pascal Migaud and Thomas Berg

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25582

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease (pages 1711–1721)

      Cynthia D. Guy, Ayako Suzuki, Marzena Zdanowicz, Manal F. Abdelmalek, James Burchette, Aynur Unalp and Anna Mae Diehl, for the NASH CRN

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25559

    2. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study (pages 1722–1726)

      Paul C. Adams, Mark Speechley, James C. Barton, Christine E. McLaren, Gordon D. McLaren and John H. Eckfeldt

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25538

    3. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver (pages 1727–1737)

      KyeongJin Kim, Suhkneung Pyo and Sung Hee Um

      Article first published online: 8 MAR 2012 | DOI: 10.1002/hep.25537

    4. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease (pages 1738–1745)

      Shelby Sullivan, Erik P. Kirk, Bettina Mittendorfer, Bruce W. Patterson and Samuel Klein

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25548

    5. Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia (pages 1746–1753)

      H. Carlijne Hassing, Hans Mooij, Shuling Guo, Brett P. Monia, Keyang Chen, Wim Kulik, Geesje M. Dallinga-Thie, Max Nieuwdorp, Erik S.G. Stroes and Kevin Jon Williams

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25580

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma (pages 1754–1765)

      Ming Liu, Leilei Chen, Tim Hon Man Chan, Jian Wang, Yan Li, Yan Li, Ting-Ting Zeng, Yun-Fei Yuan and Xin-Yuan Guan

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25584

    2. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion (pages 1766–1775)

      Florence Grise, Sandra Sena, Aurélien Bidaud-Meynard, Jessica Baud, Jean-Baptiste Hiriart, Kassem Makki, Nathalie Dugot-Senant, Cathy Staedel, Paulette Bioulac-Sage, Jessica Zucman-Rossi, Jean Rosenbaum and Violaine Moreau

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25568

    3. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition (pages 1776–1786)

      Jae Yeon Seok, Deuk Chae Na, Hyun Goo Woo, Massimo Roncalli, So Mee Kwon, Jeong Eun Yoo, Ei Yong Ahn, Gwang Il Kim, Jin-Sub Choi, Young Bae Kim and Young Nyun Park

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25570

    4. Cyclin G1–mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression (pages 1787–1798)

      Wen Wen, Jin Ding, Wen Sun, Jing Fu, Yao Chen, Kun Wu, Beifang Ning, Tao Han, Lei Huang, Cheng Chen, Dong Xie, Zhong Li, Gensheng Feng, Mengchao Wu, Weifen Xie and Hongyang Wang

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25596

    5. Genome-wide DNA methylation profiles in hepatocellular carcinoma (pages 1799–1808)

      Jing Shen, Shuang Wang, Yu-Jing Zhang, Maya Kappil, Hui-Chen Wu, Muhammad G. Kibriya, Qiao Wang, Farzana Jasmine, Habib Ahsan, Po-Huang Lee, Ming-Whei Yu, Chien-Jen Chen and Regina M. Santella

      Article first published online: 24 APR 2012 | DOI: 10.1002/hep.25569

    6. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease (pages 1809–1819)

      Srinevas K. Reddy, Jennifer L. Steel, Hui-Wei Chen, David J. DeMateo, Jon Cardinal, Jaideep Behari, Abhinav Humar, J. Wallis Marsh, David A. Geller and Allan Tsung

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25536

    7. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways (pages 1820–1829)

      Qiang Chen, Wenjiao Li, Yunyan Wan, Xiaochun Xia, Qiao Wu, Yanling Chen, Zhide Lai, Chundong Yu and Wengang Li

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25549

    8. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma (pages 1830–1839)

      Guoyuan Liu, Songmin Jiang, Chenji Wang, Wei Jiang, Zulong Liu, Chao Liu, Hexige Saiyin, Xianmei Yang, Suqin Shen, Deke Jiang, Ping Zhou, Dingding Han, Xiaohui Hu, Qing Yi and Long Yu

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25564

    9. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases (pages 1840–1851)

      Jun-Xiang Zhang, Da-Qiang Li, Aiwu Ruth He, Mona Motwani, Vasilis Vasiliou, Jeyanthy Eswaran, Lopa Mishra and Rakesh Kumar

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25566

    10. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma (pages 1852–1862)

      YuXiang Fang, Jing-Lun Xue, Qi Shen, Jinzhong Chen and Ling Tian

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25576

    11. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases (pages 1863–1875)

      Wei Yan, Ying Chang, Xiaoyan Liang, Jon S. Cardinal, Hai Huang, Stephen H. Thorne, Satdarshan P.S. Monga, David A. Geller, Michael T. Lotze and Allan Tsung

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25572

    12. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes (pages 1876–1888)

      Mina Komuta, Olivier Govaere, Vincent Vandecaveye, Jun Akiba, Werner Van Steenbergen, Chris Verslype, Wim Laleman, Jacques Pirenne, Raymond Aerts, Hirohisa Yano, Frederik Nevens, Baki Topal and Tania Roskams

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25595

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function (pages 1889–1900)

      Hisamitsu Hayashi, Kaori Inamura, Kensuke Aida, Sotaro Naoi, Reiko Horikawa, Hironori Nagasaka, Tomozumi Takatani, Tamio Fukushima, Asami Hattori, Takashi Yabuki, Ikuo Horii and Yuichi Sugiyama

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25591

    2. A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis (pages 1901–1911)

      Ping Lam, Shuhua Xu, Carol J. Soroka and James L. Boyer

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25523

    3. Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation (pages 1912–1921)

      Ursula Ehmer, Sandra Kalthoff, Bastian Fakundiny, Brigitte Pabst, Nicole Freiberg, Ronald Naumann, Michael P. Manns and Christian P. Strassburg

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25561

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Cognitive dysfunction in cirrhosis is associated with falls: A prospective study (pages 1922–1930)

      Germán Soriano, Eva Román, Joan Córdoba, Maria Torrens, Maria Poca, Xavier Torras, Càndid Villanueva, Ignasi J. Gich, Víctor Vargas and Carlos Guarner

      Article first published online: 4 APR 2012 | DOI: 10.1002/hep.25554

    2. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis (pages 1931–1941)

      Pau Sancho-Bru, José Altamirano, Daniel Rodrigo-Torres, Mar Coll, Cristina Millán, Juan José Lozano, Rosa Miquel, Vicente Arroyo, Juan Caballería, Pere Ginès and Ramon Bataller

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25614

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells (pages 1942–1953)

      Komal Ramani and Maria Lauda Tomasi

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25594

    2. Galectin-3 deficiency prevents concanavalin A–induced hepatitis in mice (pages 1954–1964)

      Vladislav Volarevic, Marija Milovanovic, Biljana Ljujic, Nada Pejnovic, Nebojsa Arsenijevic, Ulf Nilsson, Hakon Leffler and Miodrag L. Lukic

      Article first published online: 25 APR 2012 | DOI: 10.1002/hep.25542

    3. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis (pages 1965–1975)

      Antonella Pellicoro, Rebecca L. Aucott, Prakash Ramachandran, Andrew J. Robson, Jonathan A. Fallowfield, Victoria K. Snowdon, Stephen N. Hartland, Madeleine Vernon, Jeremy S. Duffield, R. Christopher Benyon, Stuart J. Forbes and John P. Iredale

      Article first published online: 18 APR 2012 | DOI: 10.1002/hep.25567

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Connecting liver and gut: Murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid (pages 1976–1984)

      Katrin Neumann, Nils Kruse, Balint Szilagyi, Ulrike Erben, Christine Rudolph, Anne Flach, Martin Zeitz, Alf Hamann and Katja Klugewitz

      Article first published online: 18 MAR 2012 | DOI: 10.1002/hep.24816

    2. An antiapoptotic role of sorting nexin 7 is required for liver development in zebrafish (pages 1985–1993)

      Liangliang Xu, Wenguang Yin, Jianhong Xia, Meixiu Peng, Song Li, Shuo Lin, Duanqing Pei and Xiaodong Shu

      Article first published online: 23 APR 2012 | DOI: 10.1002/hep.25560

  9. Liver Biology/ Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner (pages 1994–2004)

      Rachel Tanos, Rushang D. Patel, Iain A. Murray, Philip B. Smith, Andrew D. Patterson and Gary H. Perdew

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25571

  10. AASLD Practice Guideline

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (pages 2005–2023)

      Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton and Arun J. Sanyal

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25762

  11. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Phenotypic fidelity (or not?) of epithelial cells in the liver (pages 2024–2027)

      George K. Michalopoulos

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25703

    2. Insights into molecular mechanisms contributing to individual susceptibility to steatohepatitis: Lessons learned from mouse models (pages 2027–2030)

      Kurt Zatloukal

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25707

    3. Beyond reasonable doubt: Who is the culprit in lipotoxicity in NAFLD/NASH? (pages 2030–2032)

      Gavin E. Arteel

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25721

    4. A ZFN/piggyBac step closer to autologous liver cell therapy (pages 2033–2035)

      Aras N. Mattis and Holger Willenbring

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25715

  12. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Nutmeg liver and ascites resulting from a membranous web obstruction at the hepatic origin of the inferior vena cava (pages 2036–2037)

      Christopher P. Farrell, Gary Newman and Robert Atkins

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25737

  13. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Liver Biology/ Pathobiology
    11. AASLD Practice Guideline
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis (page 2038)

      Ting Wu, Feng-Cai Zhu, Shou-Jie Huang, Xue-Feng Zhang, Zhong-Ze Wang, Jun Zhang and Ning-Shao Xia

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25522

    2. Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis (page 2039)

      Ian A. Rowe, Matthew J. Armstrong, Richard Parker and Diarmaid D. Houlihan

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25588

    3. Reply (pages 2039–2040)

      Hossein Poutschi and Jacob George

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25586

    4. Cystic and papillary neoplasm involving peribiliary glands: A biliary counterpart of branch-type intraductal papillary mucinous cystic neoplasm? (pages 2040–2041)

      Yasuni Nakanuma and Yasunori Sato

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25590

      Corrected by:

      Correction: Correction

      Vol. 56, Issue 3, 1189, Article first published online: 28 AUG 2012

    5. Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands (pages 2041–2042)

      Vincenzo Cardinale, Yunfang Wang, Guido Carpino, Lola M. Reid, Eugenio Gaudio and Domenico Alvaro

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25587

    6. Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash (pages 2042–2043)

      Nicolas Dupin, Vincent Mallet, Agnès Carlotti, Anaïs Vallet-Pichard and Stanislas Pol

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25574

    7. Is the M probe really necessary to measure liver stiffness by FibroScan? (pages 2043–2044)

      Praveen Sharma and Anil Arora

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25676

    8. Reply (page 2044)

      Robert P. Myers

      Article first published online: 29 MAY 2012 | DOI: 10.1002/hep.25708

SEARCH

SEARCH BY CITATION